Which neurotransmitter system alterations are implicated in schizophrenia, possibly including several others?

Which neurotransmitter system alterations are implicated in schizophrenia, possibly including several others?

• A. Acetylcholine deficiency
• B. Dopamine activity/synthesis alterations, possibly involving serotonin, GABA, and glutamate
• C. Norepinephrine excess
• D. Endorphin imbalance

Answer: (B)

Schizophrenia is most consistently tied to disruptions in dopamine signaling, with a broader view that other neurotransmitters modulate and contribute to the illness. Dopamine activity or synthesis alterations underpin many symptoms, especially when you consider the idea that dopamine may be oversupplied in certain pathways (like mesolimbic) and undersupplied in others (like mesocortical), which helps explain positive versus negative/cognitive symptoms. The picture is widened by evidence that serotonin, GABA, and glutamate interact with dopamine systems and influence symptom patterns—for example, serotonin can alter dopamine release, GABAergic interneurons help regulate cortical networks, and glutamatergic NMDA receptor function is linked to cognitive deficits. This combination—dopamine dysregulation with possible involvement of serotonin, GABA, and glutamate—best fits the observed data. In contrast, acetylcholine deficiency, norepinephrine excess, or endorphin imbalance are not the primary or most consistently implicated patterns in schizophrenia.

Schizophrenia is most consistently tied to disruptions in dopamine signaling, with a broader view that other neurotransmitters modulate and contribute to the illness. Dopamine activity or synthesis alterations underpin many symptoms, especially when you consider the idea that dopamine may be oversupplied in certain pathways (like mesolimbic) and undersupplied in others (like mesocortical), which helps explain positive versus negative/cognitive symptoms. The picture is widened by evidence that serotonin, GABA, and glutamate interact with dopamine systems and influence symptom patterns—for example, serotonin can alter dopamine release, GABAergic interneurons help regulate cortical networks, and glutamatergic NMDA receptor function is linked to cognitive deficits. This combination—dopamine dysregulation with possible involvement of serotonin, GABA, and glutamate—best fits the observed data. In contrast, acetylcholine deficiency, norepinephrine excess, or endorphin imbalance are not the primary or most consistently implicated patterns in schizophrenia.